Protinex Diabetes Care Partners with Apollo Health Co (Apollo 24/7) to Support Diabetes Management in India
Reading Time: 3 minutes In a significant move towards promoting diabetes management and encouraging early testing, Protinex Diabetes Care partners with Apollo Health Co (Apollo 24/7) to create greater awareness around this significant health issue through Protinex Diabetes Care. Protinex
Kaivalyadhama to Host 11th International Conference on Yoga in Cancer Care, Uniting Global Experts to Explore Yoga’s Role in Holistic Cancer Support
Reading Time: 2 minutes As the global cancer burden rises to 30 million cases by 2040, healthcare systems face a critical challenge in providing supportive care for patients and survivors. Recent advancements in cancer treatments have increased survival rates to 68%, but standard treatments often cause debilitating side-effects. Lifestyle
the International Film Criticism Conference Is Launched in Riyadh
Reading Time: 2 minutes Riyadh, Saudi Arabia: The Saudi Film Commission announced the commencement of the second edition of the International Film Criticism Conference in Riyadh, running from November 6 to 10, 2024. The conference is distinguished by a vast presence of international filmmakers, critics,
Smart Health Report by Health Vectors
Reading Time: 3 minutes Health Vectors (HV), one of the leading names in healthcare technology, is transforming personal health management with its Smart Health Reports. Of the various types of Smart Reports that Health Vectors produces, the Premium Smart Report utilises personal clinical data, family history, and lifestyle factors
Kesko Corporation: Disclosure in compliance with Chapter 9, Section 10 of the Finnish Securities Markets Act (07.11.2024)
Reading Time: 2 minutes Kesko Corporation has on 8 November 2024 received a notification pursuant to Chapter 9, Section 10 of the Finnish Securities Markets Act from BlackRock, Inc. According to the notification, on 7 November 2024, BlackRock, Inc.’s holding in Kesko Corporation, including holding
Filo Reports Q3 2024 Results
Reading Time: 14 minutes VANCOUVER, BC, Nov. 8, 2024 /CNW/ – Filo Corp. (TSX: FIL) (Nasdaq First North Growth Market: FIL) (OTCQX: FLMMF) (“Filo”, or the “Company”) announces its results for the three and nine months ended September 30, 2024. Jamie Beck, President & CEO,
Bulletin from the Extraordinary General Meeting in Sivers Semiconductors AB (publ) on 8 November 2024
Reading Time: 2 minutes The Extraordinary General Meeting in Sivers Semiconductors AB (publ) (the “Company”) has been held on 8 November 2024 and in particular the following decisions were resolved. Resolution to approve the Board of Directors’ resolution on a new issue of shares to
The Board of Directors of DUG Foodtech has resolved on a directed set-off issue of approximately SEK 7 million
Reading Time: 5 minutes 8 November, 2024, Lund, Sweden The Board of Directors of DUG Foodtech AB (publ) (“DUG Foodtech” or the “Company”) has today, November 8, by virtue of authorization granted by the extraordinary general meeting on October 15, 2024, resolved on a
Resolutions of the Annual General Meeting and the Board of Directors’ organizational meeting of Nightingale Health Plc
Reading Time: 5 minutes Nightingale Health PlcCompany release8 November 2024 at 5:00 p.m. (EET) The Annual General Meeting of Nightingale Health Plc was held on 8 November 2024. The meeting was held as a fully virtual remote meeting in accordance with Chapter 5, Section
#24-385 Correction of #24-384 Information regarding issuer substitution for Credit Suisse International
Reading Time: < 1 minute Due to a merger between Credit Suisse and UBS, instrument with isin XS1973489682 will undergo an issuer substitution. Instrument previously issued by Credit Suisse International will change issuer to UBS AG with effective date 11th of November. For more details,